Admission: MicroSalt plc
MicroSalt, a spin-out from parent company Tekcapital plc, is a US-based business who, with the use of their patented technology, produce full flavour, low-sodium salt which aims to reduce excess sodium consumption by up to 50%, helping reduce cardiovascular disease globally.
Demand for reduced sodium products across both B2B and B2C has increased significantly with The World Health Organisation stating ambitions to reduce sodium intake by 30% by 2025. MicroSalt are seeking to partner with brands aiming to reduce the sodium content in both their existing and new product lines.
The proceeds of the fundraising will be used to provide the Group with the capital required to support its growth strategy and to capitalise on its pipeline of commercial opportunities with existing and potential customers.
Crowe’s role and team
Crowe acted as reporting accountant on the transaction, with the capital markets team led by Mitesh Patelia, George Lawford and Jake Harrison.
Client quote
“We greatly appreciated the assistance of Mitesh and his team at Crowe in providing invaluable support and advice to help us with our successful admission to AIM. Crowe’s ability to support US companies looking to list on AIM was a key consideration for us. This marks an important step in our development and provides an excellent platform for future growth.”
